Oncology | World Briefings

Gilead's Trodelvy: A Triplet Regimen Fails in First-Line Lung Cancer - What Does This Mean for the Future?

World

Gilead's Trodelvy: A Triplet Regimen Fails in First-Line Lung Cancer - What Does This Mean for the Future?

Gilead Sciences has been on the hunt for a win with its antibody-drug conjugate (ADC) Trodelvy after facing two surprising...

Jazz Pharmaceuticals Reports Encouraging 30-Month Survival Data for Zanidatamab in Gastric Cancer

World

Jazz Pharmaceuticals Reports Encouraging 30-Month Survival Data for Zanidatamab in Gastric Cancer

Jazz Pharmaceuticals has posted fresh phase 2 data on zanidatamab that show the HER2-targeted bispecific antibody kept 59% of people...

Lung Cancer Drug Shows Promise: TIGIT-Targeting Antibody + Jemperli Combo Shows Significant Tumor Shrinkage

World

Lung Cancer Drug Shows Promise: TIGIT-Targeting Antibody + Jemperli Combo Shows Significant Tumor Shrinkage

A targeted immunotherapy being developed by the biotech iTeos Therapeutics and GSK delivered promising response rates in patients with a...

Thrush Mistaken for Rare Cancer: Woman Urges Brits to 'Check Their Genitals'

Health

Thrush Mistaken for Rare Cancer: Woman Urges Brits to 'Check Their Genitals'

A Leeds woman is warning Brits to 'check their genitals' for signs of cancer after her disease was spotted so...

News Categories

Follow Us